The CANTOS study demonstrated that anti-inflammatory interventions can reduce the risk of coronary events. Among the many different inflammatory pathways, which one should be targeted? The challenges of proving each inflammatory hypothesis are discussed by Milton Packer (Baylor Heart and Vascular Institute Baylor University Medical Center, Dallas) at ESC18 , the annual meeting of European Society of Cardiology.
The inflammatory hypothesis after CANTOS
Dai congressiIntervisteCARDIOINFO@ESC2018
Scelti dall'editore
- The COMMANDER-HF trial
John G.F. Cleland National Heart and Lung Institute, Imperial College London
- Results of the ASCEND trial
Jane Armitage Nuffield Department of Population Health, University of Oxford, Oxford